FDA.reportPublic FDA data

HYPROMELLOSE 2910 (5 MPA.S)

Substance profile for UNII R75537T0T4, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
R75537T0T4
Preferred term
HYPROMELLOSE 2910 (5 MPA.S)
Registry number
9004-65-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1300452
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1300452https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1300452
FDA Substance Registration SystemR75537T0T4https://precision.fda.gov/uniisearch/srs/unii/R75537T0T4

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. SIMVASTATIN Tablets USP for oral use Initial U.S. Approval: 19911
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use ciprofloxacin safely and effectively. See full prescribing information for ciprofloxacin. CIPROFLOXACIN tablets USP, for oral use Initial U.S. Approval: 19871
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4AMOXICILLIN AND CLAVULANATE POTASSIUM1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4ETODOLAC3
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Metformin Hydrochloride Tablets USP Rx Only3
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN Tablet, Film Coated for Oral use Initial U.S. Approval: 19969
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4NABUMETONE2
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4QUETIAPINE FUMARATE1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4METFORMIN HYDROCHLORIDE TABLETS USP, 500 mg, 850 mg, and 1000 mg 1048 1049 7214 Rx only2
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4METFORMIN HYDROCHLORIDE TABLETS USP, 500 mg, 850 mg, and 1000 mg 1048 1049 7214 Rx only1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use carvedilol safely and effectively.See full prescribing information for carvedilol. Carvedilol Tablets, USP Initial U.S. Approval: 19951
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Metformin Hydrochloride Tablets USP Rx Only1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use clopidogrel tablets safely and effectively. See full prescribing information for clopidogrel tablets. Clopidogrel Tablets USP for oral use Initial U.S. Approval: 19971
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4d1b30723-e2b1-4772-a11e-57ba9acc93432
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets USP for oral use Initial U.S. Approval: 19914
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets USP for oral use Initial U.S. Approval: 19911
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951001
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use amoxicillin safely and effectively. See full prescribing information for amoxicillin. Amoxicillin Capsules, Tablets, and Powder for Oral Suspension Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.3
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use quetiapine fumarate tablets safely and effectively. See full prescribing information for quetiapine fumarate tablets. Quetiapine Fumarate Tablets, for oral use Initial U.S. Approval: 19975
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19921
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN Tablet, Film Coated for Oral use Initial U.S. Approval: 19967
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T471901b84-5ce2-420c-bb86-c44479fc156c4
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T434b1ac49-9386-47cc-b078-f9e0415309796
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T40a3777cf-5539-4b19-9964-149d9ca0ab2c5
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use Renagel safely and effectively. See full prescribing information for Renagel. Renagel (sevelamer hydrochloride) Tablet for Oral use Initial U.S. Approval: 20001
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4f55098b4-e653-4929-8ea6-10c933249eb12
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T48aedeb67-c3ad-460a-975e-e1b3e3cafd272
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4011d6e48-f009-4644-90bb-7d9d94b9e9282
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Metformin Hydrochloride Tablets, USP2
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4489c5c7d-75e3-4b98-b7d5-3c61e2f98adf2
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T44213db46-f17e-48f5-aa18-114b2b8143701
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Metformin Hydrochloride Tablets USP3
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP2
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use amoxicillin safely and effectively. See full prescribing information for amoxicillin. Amoxicillin Capsules, Tablets, and Powder for Oral Suspension Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4FACTIVE ® (gemifloxacin mesylate) Tablets1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Diltiazem Hydrochloride Extended-Release Capsules, USP [Once-a-Day Dosage]1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use carvedilol tablets USP safely and effectively. See full prescribing information for Carvedilol Tablets USP. Initial U.S. Approval: 19951
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4METFORMIN HYDROCHLORIDE TABLETS USP, 500 mg Rx only1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Ciprofloxacin Tablets, USP1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use levocetirizine dihydrochloride tablets safely and effectively. See full prescribing information for levocetirizine dihydrochloride tablets. LEVOCETIRIZINE dihydrochloride tablets for oral use Initial U.S. Approval: 19951
HYDROXYPROPYL METHYLCELLULOSE E5 [II]INACTIVE INGREDIENTR75537T0T42efa5aa8-9b72-4b3f-968e-3f11425ebdae1
HYDROXYPROPYL METHYLCELLULOSE E5 [II]INACTIVE INGREDIENTR75537T0T4fa34818a-cb02-4ec9-b84b-cf18e1045e742
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T41bc5a105-530b-4f62-95a7-717ce03f6b021
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4baf55093-19b1-4f94-a51c-85bc2e80fd2c1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T46f5962de-3182-4690-b9c0-716da498abe21
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4d59bf418-59c4-4cf3-839b-c794e38f10831
HYDROXYPROPYL METHYLCELLULOSE E5 [II]INACTIVE INGREDIENTR75537T0T40df380e9-98be-4a09-a3e7-ab64f920692f2
HYDROXYPROPYL METHYLCELLULOSE E5 [II]INACTIVE INGREDIENTR75537T0T4c5539569-063f-4ab1-8a86-63ece30373bf2
HYDROXYPROPYL METHYLCELLULOSE E5 [II]INACTIVE INGREDIENTR75537T0T4c9e714f2-b536-4bc2-a27a-6f9e8f931ad32
HYDROXYPROPYL METHYLCELLULOSE E5 [II]INACTIVE INGREDIENTR75537T0T49a277e3e-dd0c-4c88-a2d3-ae27fb19041e5
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use EXALGO ® safely and effectively. See full prescribing information for EXALGO. EXALGO (hydromorphone HCl) Extended-Release Tablets, for oral use, CII Initial U.S. Approval: 19841
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951000
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Citalopram Tablets USP1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Citalopram Tablets USP1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Citalopram Tablets USP1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use Renagel safely and effectively. See full prescribing information for Renagel. Renagel (sevelamer hydrochloride) Tablet for Oral use Initial U.S. Approval: 20003
HYDROXYPROPYL METHYLCELLULOSE E5 [II]INACTIVE INGREDIENTR75537T0T43bebaa59-ef09-472b-af92-ec6b135898492
HYDROXYPROPYL METHYLCELLULOSE E5 [II]INACTIVE INGREDIENTR75537T0T4e9537bbe-e63b-4440-af70-5d32853ecf1f2
HYDROXYPROPYL METHYLCELLULOSE E5 [II]INACTIVE INGREDIENTR75537T0T40642f4f2-d3ae-4c8d-b8d3-585681638e931
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use carvedilol tablets USP safely and effectively. See full prescribing information for carvedilol tablets USP. CARVEDILOL tablets USP for oral use Initial U.S. Approval: 19951
HYDROXYPROPYL METHYLCELLULOSE E5 [II]INACTIVE INGREDIENTR75537T0T4CETAFEN EXTRA1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19923
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Cefprozil Tablets USP, 250 mg and 500 mg1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use bicalutamide safely and effectively. See full prescribing information for bicalutamide. Bicalutamide Tablets USP for Oral use Initial U.S. Approval : 19951
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use clopidogrel tablets safely and effectively. See full prescribing information for clopidogrel tablets. Clopidogrel Tablets USP Initial U.S. Approval: 19972
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4d54a97d5-3664-4ca5-bffd-8366c7255b738
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Metformin Hydrochloride Tablets USP Rx Only2
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use quetiapine fumarate tablets safely and effectively. See full prescribing information for quetiapine fumarate tablets. Quetiapine Fumarate Tablets Initial U.S. Approval: 199 72
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Citalopram Tablets, USP5
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Amoxicillin Capsules, Tablets and Powder for Oral Suspension, USP6
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use Zolpidem Tartrate Tablets, USP safely and effectively. See full prescribing information for Zolpidem Tartrate Tablets, USP. Zolpidem Tartrate Tablets, USP - CIV Initial U.S. Approval: 19927
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19953
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use EXALGO™ safely and effectively. See full prescribing information for EXALGO. EXALGO (hydromorphone HCl) Extended-Release Tablets, CII Initial U.S. Approval: 19841
Hypromellose 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T48a023942-01e8-4849-aa3c-1a640ffc7fd37
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Bisoprolol Fumarate Tablets USP2
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use carvedilol tablets USP safely and effectively. See full prescribing information for carvedilol tablets USP. CARVEDILOL tablets USP for oral use Initial U.S. Approval: 19951
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19921
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Bisacodyl USP 5 mg Laxative3
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4CIPROFLOXACIN TABLETS, USP1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Ciproflaxin Tablets1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19952
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP for Oral Use Initial U.S. Approval: 19923
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T43e463126-78a9-4ec5-904c-0424a64d8ae81
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4ASPIRIN ENTERIC COATED ORANGE TABLETS, 325 mg1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4ACETAMINOPHEN CAPLETS, 500 mg2
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T49dac97a5-c992-4601-af93-138bfe2302a81
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use zolpidem tartrate safely and effectively. See full prescribing information for zolpidem tartrate tablets. Zolpidem Tartrate Tablets CIV Initial U.S. Approval: 19921
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4Bisoprolol Fumarate Tablets USP1
HYPROMELLOSE 2910 (5 CPS)INACTIVE INGREDIENTR75537T0T4CIPROFLOXACIN TABLETS, USP1
HYPROMELLOSE 2910 (5 CPS)INACTIVE INGREDIENTR75537T0T4CIPROFLOXACIN TABLETS, USP1
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T488f1abdc-f53e-4ff9-b4c1-3cfbc2609b791
HYPROMELLOSE 2910 (5 CPS)INACTIVE INGREDIENTR75537T0T4Metformin Hydrochloride Tablets, USP1
HYPROMELLOSE 2910 (5 CPS)INACTIVE INGREDIENTR75537T0T4These highlights do not include all the information needed to use Ranexa safely and effectively. See full prescribing information for Ranexa. Ranexa (ranolazine) extended-release tablets Initial U.S. Approval: 20062
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4TAMOXIFEN CITRATE TABLETS USP, 10 mg and 20 mg (base) 0784 0782 Rx only2
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3282
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4ONDANSETRON HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3071
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4QUETIAPINE FUMARATE TABLET, FILM COATED [BRYANT RANCH PREPACK]1003
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4ANASTROZOLE TABLET [BRYANT RANCH PREPACK]1001
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4BICALUTAMIDE TABLET [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4BISOPROLOL FUMARATE TABLET [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4IRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4LAMIVUDINE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4LOSARTAN POTASSIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4TACROLIMUS CAPSULE, GELATIN COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4EXALGO (HYDROMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [MALLINCKRODT, INC]36
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4CITALOPRAM TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.]31
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) GRANULE, DELAYED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]26
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4CIPROFLOXACIN TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]19
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4QUETIAPINE FUMARATE TABLET QUETIAPINE FUMARATE (QUETIAPINE FUMARATE ) TABLET [ASCEND LABORATORIES, LLC]18
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4RISPERIDONE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]17
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED AMOXICILLIN AND CLAVULANATE POTASSIUM POWDER, FOR SUSPENSION AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]16
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4CARVEDILOL (CARVEDILOL) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]16
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4DOXYCYCLINE HYCLATE DELAYED RELEASE (DOXYCYCLINE HYCLATE) TABLET, DELAYED RELEASE [HERITAGE PHARMACEUTICALS INC.]16
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4LEVETIRACETAM TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]15